Skip to content

Capturing and monitoring global differences in untreated and treated ESKD, KRT modality, and outcomes

Research output: Contribution to journalReview article

  • Roberto Pecoits-Filho
  • Ikechi G Okpechi
  • Jo-Ann Donner
  • David C H Harris
  • Harith M Aljubori
  • Aminu K Bello
  • Ezequiel Bellorin-Font
  • Fergus J Caskey
  • Allan Collins
  • Alfonso M Cueto-Manzano
  • John Feehally
  • Bak Leong Goh
  • Kitty J Jager
  • et al.
Original languageEnglish
JournalKidney International Supplements
DateAccepted/In press - 7 Nov 2019


A large gap between the number of people with end-stage kidney disease (ESKD) who received kidney replacement therapy (KRT) and those who needed it has been recently identified, and it is estimated that approximately one half to three quarters of all people with ESKD in the world may have died prematurely because they could not receive KRT. This estimate is aligned with a previous report that estimated that more than 3 million people in the world died each year because they could not access KRT. In this article, we discuss the reasons for the differences in treated and untreated ESKD, KRT modalities and outcomes, and present strategies to close the global KRT gap by establishing robust health information systems to guide resource allocation to areas of need, inform KRT service planning, enable policy development, and monitor KRT health outcomes.

    Research areas

  • end-stage kidney disease, global health, health information systems, health services accessibility, registries, kidney replacement therapy



  • Full-text PDF (author’s accepted manuscript)

    Accepted author manuscript, 175 KB, PDF document

    Embargo ends: 1/01/99

    Request copy

View research connections

Related faculties, schools or groups